ACH (Accendra Health) Moat Score: 2/10 (As of Jun. 27, 2026)


ACH Accendra Health Inc ACH
57 GF Score
Price $3.34
GF Value $5.02
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Accendra Health Moat Score?

Accendra Health ACH +5.36% 57 Moat Score is 2 as of Jun. 27, 2026. GuruFocus rates ACH with a GF Score™ of 57/100 and a GF Value™ of $5.02 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 121 Medical Distribution companies, Accendra Health ranks better than 82.64% on this metric.

Accendra Health has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Accendra Health has No Moat: Accendra Health operates in a competitive healthcare sector with limited market share and lacks significant intellectual property or regulatory barriers. Its competitive position is weak, with no discernible moat characteristics.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Accendra Health might have No Moat - Very weak/transient advantages.

Accendra Health  (NYSE:ACH) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Accendra Health Moat Score Related Terms

ACH vs EDAP, YI, COSM: Moat Score Comparison

For the Medical Distribution subindustry, Accendra Health's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accendra Health Moat Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Accendra Health's Moat Score distribution charts can be found below:

* The bar in red indicates where Accendra Health's Moat Score falls into.


ACH
57GF Score
Accendra Health Inc ACH
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Accendra Health (ACH) has a Moat Score of 2 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Accendra Health ranks #21 out of 121 companies in the Medical Distribution industry, placing it in the top 17.4%.
Is Accendra Health's Moat Score too high?
Accendra Health's current Moat Score is 2. Based on the distribution chart, Accendra Health ranks #21 out of 121 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Moat Score compare to EDAP and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #21 out of 121 companies for Moat Score. This places Accendra Health in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Distribution company?
A good Moat Score depends on the Medical Distribution industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Accendra Health's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.34 — trading 33.5% below its estimated fair value. The current Moat Score is 2. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Accendra Health (ACH), the current Moat Score is 2 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (ACH) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of $3.34 is trading 33.5% below its estimated GF Value™ of $5.02. GuruFocus considers Accendra Health to be Possible Value Trap.

Key valuation signals for ACH:

  • Moat Score: 2
  • GF Value™: $5.02 vs. price of $3.34 (33.5% below fair value)
  • GF Score™: 57/100 with 7 warning signs

No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accendra Health Business Description

Other Exchanges 6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score

Get the complete analysis for ACH

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.34
Price
$5.02
GF Value